Literature DB >> 26574233

Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation.

Latt S Mansor1, Keshavi Mehta1, Dunja Aksentijevic2, Carolyn A Carr1, Trine Lund3, Mark A Cole4, Lydia Le Page1, Maria da Luz Sousa Fialho1, Michael J Shattock2, Ellen Aasum3, Kieran Clarke1, Damian J Tyler1, Lisa C Heather1.   

Abstract

KEY POINTS: Adaptation to hypoxia makes the heart more oxygen efficient, by metabolising more glucose. In contrast, type 2 diabetes makes the heart metabolise more fatty acids. Diabetes increases the chances of the heart being exposed to hypoxia, but whether the diabetic heart can adapt and respond is unknown. In this study we show that diabetic hearts retain the ability to adapt their metabolism in response to hypoxia, with functional hypoxia signalling pathways. However, the hypoxia-induced changes in metabolism are additive to abnormal baseline metabolism, resulting in hypoxic diabetic hearts metabolising more fat and less glucose than controls. This stops the diabetic heart being able to recover its function when stressed. These results demonstrate that the diabetic heart retains metabolic flexibility to adapt to hypoxia, but is hindered by the baseline effects of the disease. This increases our understanding of how the diabetic heart is affected by hypoxia-associated complications of the disease. ABSTRACT: Hypoxia activates the hypoxia-inducible factor (HIF), promoting glycolysis and suppressing mitochondrial respiration. In the type 2 diabetic heart, glycolysis is suppressed whereas fatty acid metabolism is promoted. The diabetic heart experiences chronic hypoxia as a consequence of increased obstructive sleep apnoea and cardiovascular disease. Given the opposing metabolic effects of hypoxia and diabetes, we questioned whether diabetes affects cardiac metabolic adaptation to hypoxia. Control and type 2 diabetic rats were housed for 3 weeks in normoxia or 11% oxygen. Metabolism and function were measured in the isolated perfused heart using radiolabelled substrates. Following chronic hypoxia, both control and diabetic hearts upregulated glycolysis, lactate efflux and glycogen content and decreased fatty acid oxidation rates, with similar activation of HIF signalling pathways. However, hypoxia-induced changes were superimposed on diabetic hearts that were metabolically abnormal in normoxia, resulting in glycolytic rates 30% lower, and fatty acid oxidation 36% higher, in hypoxic diabetic hearts than hypoxic controls. Peroxisome proliferator-activated receptor α target proteins were suppressed by hypoxia, but activated by diabetes. Mitochondrial respiration in diabetic hearts was divergently activated following hypoxia compared with controls. These differences in metabolism were associated with decreased contractile recovery of the hypoxic diabetic heart following an acute hypoxic insult. In conclusion, type 2 diabetic hearts retain metabolic flexibility to adapt to hypoxia, with normal HIF signalling pathways. However, they are more dependent on oxidative metabolism following hypoxia due to abnormal normoxic metabolism, which was associated with a functional deficit in response to stress.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26574233      PMCID: PMC4713751          DOI: 10.1113/JP271242

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  49 in total

Review 1.  Systematic review of the association between lung function and Type 2 diabetes mellitus.

Authors:  O L Klein; J A Krishnan; S Glick; L J Smith
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

2.  Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.

Authors:  Nandakumar Sambandam; Dominique Morabito; Cory Wagg; Brian N Finck; Daniel P Kelly; Gary D Lopaschuk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-09       Impact factor: 4.733

3.  Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

Authors:  J M Huss; F H Levy; D P Kelly
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

4.  Prevalence of obstructive sleep apnoea in men with type 2 diabetes.

Authors:  S D West; D J Nicoll; J R Stradling
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

5.  Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.

Authors:  Nicholas D Oakes; Pia Thalén; Ellen Aasum; Amanda Edgley; Terje Larsen; Stuart M Furler; Bengt Ljung; David Severson
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-13       Impact factor: 4.310

6.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function.

Authors:  Sergiu-Bogdan Catrina; Kensaku Okamoto; Teresa Pereira; Kerstin Brismar; Lorenz Poellinger
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart.

Authors:  Wanli Xue; Yanlong Liu; Jingchan Zhao; Lu Cai; Xiaokun Li; Wenke Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

8.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study.

Authors:  Helaine E Resnick; Susan Redline; Eyal Shahar; Adele Gilpin; Anne Newman; Robert Walter; Gordon A Ewy; Barbara V Howard; Naresh M Punjabi
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  Prevalence and mortality of acute myocardial infarction in patients with diabetes.

Authors:  L Rytter; S Troelsen; H Beck-Nielsen
Journal:  Diabetes Care       Date:  1985 May-Jun       Impact factor: 19.112

10.  Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved.

Authors:  H R Cross; L H Opie; G K Radda; K Clarke
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

View more
  23 in total

Review 1.  Turning the Oxygen Dial: Balancing the Highs and Lows.

Authors:  Alan H Baik; Isha H Jain
Journal:  Trends Cell Biol       Date:  2020-05-05       Impact factor: 20.808

2.  PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.

Authors:  Rui Wang; Lei Xi; Rakesh C Kukreja
Journal:  J Pharmacol Exp Ther       Date:  2017-01-25       Impact factor: 4.030

3.  Relation of Hypoxia Inducible Factor, Dyslipidemia and CAD Saudi Patients With Type 2 Diabetes.

Authors:  Amal F Gharib; Taisir Saber; Ahmad El Askary; Afaf Alharthi; Nouf Ali Alsalmi; Saja Talal Alhashmi; Rana Fawaz Al-Asiri; Alaa Shafie
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 4.  Guidelines on models of diabetic heart disease.

Authors:  Lisa C Heather; Anne D Hafstad; Ganesh V Halade; Romain Harmancey; Kimberley M Mellor; Paras K Mishra; Erin E Mulvihill; Miranda Nabben; Michinari Nakamura; Oliver J Rider; Matthieu Ruiz; Adam R Wende; John R Ussher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-03       Impact factor: 5.125

5.  Potential role for pyruvate kinase M2 in the regulation of murine cardiac glycolytic flux during in vivo chronic hypoxia.

Authors:  Michal K Handzlik; David J Tooth; Dumitru Constantin-Teodosiu; Paul L Greenhaff; Mark A Cole
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

6.  Metabolic Remodeling in Diabetic Cardiomyopathy.

Authors:  Cher-Rin Chong; Kieran Clarke; Eylem Levelt
Journal:  Cardiovasc Res       Date:  2017-02-08       Impact factor: 10.787

7.  Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.

Authors:  Latt S Mansor; Maria da Luz Sousa Fialho; Georgina Yea; Will A Coumans; James A West; Matthew Kerr; Carolyn A Carr; Joost J F P Luiken; Jan F C Glatz; Rhys D Evans; Julian L Griffin; Damian J Tyler; Kieran Clarke; Lisa C Heather
Journal:  Cardiovasc Res       Date:  2017-06-01       Impact factor: 10.787

8.  Metabolic Suppression of HIF-1α Contributes to Susceptibility of Ischemic Injury in Diabetic Hearts.

Authors:  Adam De Jesus; Hsiang-Chun Chang; Hossein Ardehali
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

9.  Increasing cardiac pyruvate dehydrogenase flux during chronic hypoxia improves acute hypoxic tolerance.

Authors:  Michal K Handzlik; Dumitru Constantin-Teodosiu; Paul L Greenhaff; Mark A Cole
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

10.  Intracellular sodium elevation reprograms cardiac metabolism.

Authors:  Dunja Aksentijević; Anja Karlstaedt; Marina V Basalay; Brett A O'Brien; David Sanchez-Tatay; Seda Eminaga; Alpesh Thakker; Daniel A Tennant; William Fuller; Thomas R Eykyn; Heinrich Taegtmeyer; Michael J Shattock
Journal:  Nat Commun       Date:  2020-08-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.